This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients worldwide.View EW key stats
Edwards Lifesciences Corp - EW - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates Edwards Lifesciences Corp as a
Buy with a ratings score of B.
Report Snippet: We rate EDWARDS LIFESCIENCES CORP (EW) a BUY. This is driven by a few notable strengths, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity and expanding profit margins. We feel its strengths outweigh the fact that the company shows weak operating cash flow.